nitroblue tetrazolium has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Youdim, MB | 1 |
| Daya, S; Maharaj, DS; Maharaj, H; Mohanakumar, KP; Saravanan, KS | 1 |
2 other study(ies) available for nitroblue tetrazolium and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Oxidation by rat brain of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) coupled to tetrazolium nitro blue.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; In Vitro Techniques; Kinetics; Monoamine Oxidase Inhibitors; Nitroblue Tetrazolium; Oxidation-Reduction; Pyridines; Rats; Tetrazolium Salts | 1985 |
Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Acetaminophen; Analgesics, Non-Narcotic; Animals; Aspirin; Dopamine; Dopamine Agents; Lipid Peroxidation; Male; Neostriatum; Neurotoxicity Syndromes; Neurotoxins; Nitroblue Tetrazolium; Prosencephalon; Rats; Rats, Sprague-Dawley; Superoxides | 2004 |